Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-Q, Date: 2011-11-14, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: SKBI/20111114/10-Q/1/000.htm SEC Original: v240211_10q.htm
SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX PageNo. 3 PART I.FINANCIAL INFORMATION Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of September 30, 2011 (unaudited) and December 31, 2010 F-1ndensednsolidated Statements ofome and Othermprehensiveomefor the Three and Nine Months Ended September 30, 2011 and 2010 (unaudited)

---

---

Webplus: SKBI/20111114/10-Q/2_EX-31.1/000.htm SEC Original: v240211_ex31-1.htm
SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, WeibingLu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the

---

---

Webplus: SKBI/20111114/10-Q/3_EX-31.2/000.htm SEC Original: v240211_ex31-2.htm
SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: SKBI/20111114/10-Q/4_EX-32.1/000.htm SEC Original: v240211_ex32-1.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. WeibingLu Chief Executive Officer November 14, 2011 v240211_ex32-1.htm

---

---

Webplus: SKBI/20111114/10-Q/5_EX-32.2/000.htm SEC Original: v240211_ex32-2.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Bing Mei Chief Financial Officer November 14, 2011

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-Q, Date: 2011-11-14, XBRL Interactive FinancialsCIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE